
Dr Manley West is an emeritus professor and administrator who runs a pharmacology lab at the University of the West Indies (UWI) campus in Kingston. He has worked with ophthalmologist Dr Albert Lockhart on pioneering research that turns raw ganja into specialty medicines for glaucoma and other disorders.West and Lockhart were trained at prestigious academies in England, Scotland and the United States.
West has been the head of UWI's pharmacology department, and has nearly 40 years of experience in medicine and health. Lockhart has 36 years experience as a researcher and ophthalmologist. The lauded duo has received two of Jamaica's highest medical honors: the Order of Merit for Medicine and the Musgrave Gold Medal. Why were they honored? Because they created Canasol, a ganja-based medicine that helps decrease intraocular pressure with none of the side effects caused by other treatments.West explained that he and Lockhart began studying cannabis-glaucoma pharmacology in the early 1970's. Scientists had long known that cannabis lowered intraocular pressure, but instead of utilizing whole smoked cannabis, American researchers spent millions of dollars on a poorly-designed topical THC eyedrop treatment that had caused eye irritation and failed to decrease intraocular pressure.While Randall smoked ganja, found it a miracle medicine, and fought the US government's attempts to prevent him from using it, West and Lockhart were doing innovative experiments to determine which ganja constituents were responsible for marijuana's anti-glaucoma effects. The Jamaican government granted them an official new drug certification for Canasol in February 1983."It was a breakthrough," West explained.
"I had long been interested in finding therapeutic compounds derived from natural origins. Glaucoma hits blacks sooner in life, progresses faster, and more often results in blindness. About 100,000 of our 3 million island population has it. Other glaucoma medications produced side effects, and the only other treatment was surgery, which is also risky. We wanted a safer, more affordable medicine for Jamaicans.
Canasol appears to be the answer. It works within minutes to lower pressure, even in patients who have rare forms of glaucoma or have not responded well to other treatments."
BY NATALIE ESCOBAR NIÑO 200620842